| Oxygenta Pharmaceutical Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524636 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE102E01018 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : -9.92 |
Market Cap(₹Cr) : 225.75 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 14.30 | 15.13 | 49.47 | 33.21 | 14.01 | 12.62 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 14.30 | 15.13 | 49.47 | 33.21 | 14.01 | 12.62 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | -0.06 | 0.17 | 0.05 | 0.49 | 0.75 | 0.02 |
| Total Income | 14.25 | 15.30 | 49.52 | 33.69 | 14.75 | 12.64 |
| Total Expenditure | 18.88 | 21.98 | 51.42 | 37.56 | 16.18 | 14.40 |
| PBIDT | -4.63 | -6.67 | -1.90 | -3.87 | -1.42 | -1.76 |
| Interest | 0.95 | 0.63 | 2.13 | 0.39 | 0.69 | 0.41 |
| PBDT | -5.58 | -7.30 | -4.03 | -4.26 | -2.11 | -2.17 |
| Depreciation | 0.86 | 0.85 | -0.23 | 0.71 | 0.66 | 0.65 |
| Tax | 0.00 | 0.00 | 0.16 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.51 | -2.04 | -1.81 | -1.03 | 0.08 | -1.45 |
| Reported Profit After Tax | -4.93 | -6.11 | -2.15 | -3.93 | -2.85 | -1.36 |
| Extra-ordinary Items | 0.00 | -0.01 | -0.26 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -4.93 | -6.10 | -1.89 | -3.93 | -2.85 | -1.36 |
| EPS (Unit Curr.) | -1.33 | -1.65 | -0.60 | 1.07 | -0.81 | -0.39 |
| EPS (Adj) (Unit Curr.) | -1.33 | -1.65 | -0.60 | 1.07 | -0.81 | -0.39 |
| Calculated EPS (Unit Curr.) | -1.33 | -1.65 | -0.58 | -1.06 | -0.80 | -0.38 |
| Calculated EPS (Adj) (Unit Curr.) | -1.33 | -1.65 | -0.58 | -1.06 | -0.80 | -0.38 |
| Calculated EPS (Ann.) (Unit Curr.) | -5.33 | -6.60 | -2.33 | -4.25 | -3.22 | -1.54 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -5.33 | -6.60 | -2.33 | -4.25 | -3.22 | -1.54 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 36.98 | 36.98 | 36.98 | 36.98 | 35.48 | 35.48 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -32.38 | -44.08 | -3.84 | -11.65 | -10.14 | -13.95 |
| PBDTM(%) | -39.02 | -48.25 | -8.15 | -12.83 | -15.06 | -17.19 |
| PATM(%) | -34.48 | -40.38 | -4.35 | -11.83 | -20.34 | -10.78 |